Mobile Site ›

Risk Stratification in Chronic Lymphocytic Leukemia

The Role of the Clinical Laboratory

Risk Assessment

Slide 3

November 2008

This slide highlights the three key points that a laboratory needs to be aware of in evaluating patients with CLL.

First, one needs to reach an accurate and correct diagnosis.

Second, in today’s environment, risk assessment is critical in order to help clinicians provide the appropriate therapy and follow-up for these patients.

Finally, there is the assessment of outcome and potentially the detection of minimal residual disease. As I mentioned previously, the diagnostic and outcome assessment were previously discussed, and today we will be focusing on risk assessment.

Risk Assessment


Jump to section: